Catalyst Pharmaceuticals (CPRX, $15.13) was a top loser this month, diving -1 to $15.13 per share. Of the 917 stocks analyzed in the Biotechnology Industry throughout this month, of them (1) exhibited an Uptrend while of them (8) were in a Downtrend.